This is a Validated Antibody Database (VAD) review about human OAS1, based on 5 published articles (read how Labome selects the articles), using OAS1 antibody in all methods. It is aimed to help Labome visitors find the most suited OAS1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
OAS1 synonym: E18/E16; IFI-4; OIAS; OIASI; 2'-5'-oligoadenylate synthase 1; (2-5')oligo(A) synthase 1; 2',5'-oligo A synthetase 1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa; 2'-5'-oligoisoadenylate synthetase 1; 2-5A synthase 1; 2-5A synthetase 1; E16 (2'-5') oligo A synthetase

Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (F-3)
  • western blot knockout validation; human; 1:200; fig 1a
In order to determine which 2',5'-oligoadenylate synthetase regulates RNase L activation during viral infection, Santa Cruz Biotechnology OAS1 antibody (Santa Cruz, noca) was used in western blot knockout validation on human samples at 1:200 (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
Cell Signaling Technology
rabbit monoclonal ( D1W3A )
  • western blot knockout validation; human; 1:1000; fig 1a
In order to determine which 2',5'-oligoadenylate synthetase regulates RNase L activation during viral infection, Cell Signaling Technology OAS1 antibody (Cell Signaling, D1W3A) was used in western blot knockout validation on human samples at 1:1000 (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (F-3)
  • western blot knockout validation; human; 1:200; fig 1a
In order to determine which 2',5'-oligoadenylate synthetase regulates RNase L activation during viral infection, Santa Cruz Biotechnology OAS1 antibody (Santa Cruz, noca) was used in western blot knockout validation on human samples at 1:200 (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (18-K)
  • western blot; human; fig 1
Santa Cruz Biotechnology OAS1 antibody (Santa Cruz Biotechnology, sc-100639) was used in western blot on human samples (fig 1). Liver Int (2014) ncbi
Cell Signaling Technology
rabbit monoclonal ( D1W3A )
  • western blot; human; loading ...; fig 1b
Cell Signaling Technology OAS1 antibody (Cell Signaling, 14498) was used in western blot on human samples (fig 1b). J Virol (2018) ncbi
rabbit monoclonal ( D1W3A )
  • western blot; human; loading ...; fig 2e
Cell Signaling Technology OAS1 antibody (Cell Signaling, 14498) was used in western blot on human samples (fig 2e). Mol Cell Proteomics (2018) ncbi
rabbit monoclonal ( D1W3A )
  • western blot; human; fig 3b
Cell Signaling Technology OAS1 antibody (Cell Signaling, 14498) was used in western blot on human samples (fig 3b). Mol Cancer Res (2017) ncbi
rabbit monoclonal ( D1W3A )
  • western blot knockout validation; human; 1:1000; fig 1a
In order to determine which 2',5'-oligoadenylate synthetase regulates RNase L activation during viral infection, Cell Signaling Technology OAS1 antibody (Cell Signaling, D1W3A) was used in western blot knockout validation on human samples at 1:1000 (fig 1a). Proc Natl Acad Sci U S A (2016) ncbi
Articles Reviewed
  1. Liu R, Moss B. Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State. J Virol. 2018;92: pubmed publisher
  2. Kostas M, Haugsten E, Zhen Y, Sørensen V, Szybowska P, Fiorito E, et al. Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors. Mol Cell Proteomics. 2018;17:850-870 pubmed publisher
  3. Walter K, Goodman M, Singhal H, Hall J, Li T, Holloran S, et al. Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer. Mol Cancer Res. 2017;15:1331-1340 pubmed publisher
  4. Li Y, Banerjee S, Wang Y, Goldstein S, Dong B, Gaughan C, et al. Activation of RNase L is dependent on OAS3 expression during infection with diverse human viruses. Proc Natl Acad Sci U S A. 2016;113:2241-6 pubmed publisher
  5. Hou Z, Han Q, Zhang C, Tian Z, Zhang J. miR146a impairs the IFN-induced anti-HBV immune response by downregulating STAT1 in hepatocytes. Liver Int. 2014;34:58-68 pubmed publisher